IQV
IQVIA Holdings Inc
NYSE: IQV · HEALTHCARE · DIAGNOSTICS & RESEARCH
$156.66
-1.46% today
Updated 2026-04-29
Market cap
$26.30B
P/E ratio
20.01
P/S ratio
1.61x
EPS (TTM)
$7.83
Dividend yield
—
52W range
$135 – $247
Volume
1.8M
IQVIA Holdings Inc (IQV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.92B | $4.33B | $4.87B | $5.10B | $5.46B | $5.74B | $6.82B | $9.70B | $10.41B | $11.09B | $11.36B | $13.87B | $14.41B | $14.98B | $15.40B | $16.31B |
| Revenue growth (YoY) | — | +10.3% | +12.4% | +4.8% | +7.1% | +5.1% | +18.8% | +42.4% | +7.3% | +6.5% | +2.4% | +22.1% | +3.9% | +4.0% | +2.8% | +5.9% |
| Cost of revenue | $2.80B | $3.19B | $3.63B | $3.76B | $3.96B | $4.12B | $4.75B | $6.30B | $6.75B | $7.30B | $7.50B | $9.23B | $9.38B | $9.74B | $10.03B | $12.02B |
| Gross profit | $1.12B | $1.14B | $1.23B | $1.34B | $1.50B | $1.62B | $2.07B | $3.40B | $3.67B | $3.79B | $3.86B | $4.64B | $5.03B | $5.24B | $5.38B | $4.29B |
| Gross margin | 28.5% | 26.4% | 25.3% | 26.2% | 27.5% | 28.3% | 30.3% | 35.1% | 35.2% | 34.2% | 34.0% | 33.5% | 34.9% | 35.0% | 34.9% | 26.3% |
| R&D | — | $9.45M | $10.43M | $4.96M | $4.98M | $3.34M | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| SG&A | — | $760.40M | $803.25M | $815.41M | $882.34M | $920.99M | $1.01B | $1.60B | $1.72B | $1.73B | $1.79B | $1.96B | $2.07B | $2.05B | $1.99B | $2.00B |
| Operating income | $395.00M | $345.25M | $396.44M | $462.33M | $590.39M | $646.61M | $642.00M | $719.00M | $741.00M | $777.00M | $731.00M | $1.39B | $1.80B | $1.98B | $2.20B | $2.29B |
| Operating margin | 10.1% | 8.0% | 8.1% | 9.1% | 10.8% | 11.3% | 9.4% | 7.4% | 7.1% | 7.0% | 6.4% | 10.0% | 12.5% | 13.2% | 14.3% | 14.0% |
| EBITDA | $467.37M | $385.74M | $500.09M | $554.13M | $723.00M | $768.00M | $849.00M | $1.65B | $1.88B | $2.00B | $2.08B | $2.77B | $2.91B | $3.26B | $3.45B | $3.46B |
| EBITDA margin | 11.9% | 8.9% | 10.3% | 10.9% | 13.2% | 13.4% | 12.5% | 17.0% | 18.1% | 18.0% | 18.3% | 19.9% | 20.2% | 21.7% | 22.4% | 21.2% |
| EBIT | $383.16M | $293.74M | $401.80M | $446.62M | $601.99M | $640.26M | $560.00M | $640.00M | $742.00M | $799.00M | $789.00M | $1.50B | $1.78B | $2.13B | $2.34B | $2.32B |
| Interest expense | $141.43M | $109.06M | $134.37M | $123.51M | $100.59M | $101.79M | $144.00M | $346.00M | $414.00M | $447.00M | $416.00M | $375.00M | $416.00M | $672.00M | $670.00M | $729.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $160.60M | $241.77M | $177.55M | $226.59M | $356.38M | $387.20M | $115.00M | $1.31B | $259.00M | $191.00M | $279.00M | $966.00M | $1.09B | $1.36B | $1.37B | $1.36B |
| Net income growth (YoY) | — | +50.5% | -26.6% | +27.6% | +57.3% | +8.6% | -70.3% | +1038.3% | -80.2% | -26.3% | +46.1% | +246.2% | +12.9% | +24.5% | +1.1% | -0.9% |
| Profit margin | 4.1% | 5.6% | 3.6% | 4.4% | 6.5% | 6.7% | 1.7% | 13.5% | 2.5% | 1.7% | 2.5% | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |